Abstract
Objective Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms. Visual impairments, such as strabismus (misalignment of the eyes during gaze holding), affect up to two-thirds of PD patients, impacting their quality of life. Conventional treatments offer limited relief, prompting exploration of alternatives like deep brain stimulation (DBS) of subthalamic nucleus (STN). This pilot study aims to assess whether STN DBS can alleviate PD-related strabismus and identify specific STN regions associated with favorable outcomes. We hypothesize that STN DBS improves strabismus by modulating subthalamic connectivity with the cerebellum, hence volume of activate tissue (VTA) generated with DBS will be in dorsal STN.
Methods We studied 12 PD patients with bilateral STN DBS and five healthy controls. Clinical assessments, eye movement measurements using high-resolution eye tracking, and patient-specific DBS models were employed. Analysis included the VTA models, revealing distinct effects based on the location within the STN.
Results We found significant strabismus in 66% of PD patients. STN DBS improved strabismus in 75% of cases. The improvement was associated with dorsal STN stimulation. STN DBS exacerbated strabismus in 25% of PD patients. The VTA in these participants were located in the ventral aspect of the STN.
Discussion The findings highlight the significant effects of STN DBS on strabismus in PD, further offering insights into the complex interplay between neurodegeneration and control of eye alignment. This approach, combining clinical assessments, advanced eye tracking, and DBS computational modeling, contributes valuable knowledge towards targeted interventions for visual impairments in PD.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05400499
Funding Statement
Department of VA Rehab R&D Spire (I21RX003878)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Department of Veterans Affairs Institutional Review Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding:
The work was supported by Federal Government Funding
NIH R01NS119520 (McIntyre)
Department of VA Rehab R&D Spire I21RX003878 (Shaikh)
Other funding included Career Development Grant from the American Academy of Neurology, George C. Cotzias Memorial Fellowship, Network Models in Dystonia grant from the Dystonia Medical Research Foundation, CareSource Ohio Community Partnership Grant, and philanthropic funds for the Department of Neurology at University Hospitals.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.